Literature DB >> 26754036

Epidemiology of epilepsy.

C Behr1, M A Goltzene2, G Kosmalski3, E Hirsch2, P Ryvlin4.   

Abstract

Epilepsy is a burden affecting no fewer than 50 million patients worldwide. It is a heterogeneous group of disorders comprising both common and very rare forms, thus rendering its epidemiological investigations rather difficult. Moreover, making an epilepsy diagnosis per se can be challenging due to an evolving system of classification, and its dependency on local habits and culture. Any attempt at meta-analyses must consider such biases when pooling data from different centers and countries. Differentiating a contextual seizure from chronic epilepsy is every epileptologist's daily mission, yet it is also crucial for achieving a proper estimation of the epidemiology of epilepsy. Our present objective was to provide an overview of the epidemiology of both syndromic and non-syndromic epilepsy. Most epileptic syndromes tend to be rare and, thus, the feasibility of epidemiological quantification in populations is also addressed. Regarding its prevalence and cost, epilepsy deserves greater attention than it generally receives, as it appears to continue to be a condition under persistent taboos.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Classification; Epidemiology; Epilepsy; Rare

Mesh:

Year:  2016        PMID: 26754036     DOI: 10.1016/j.neurol.2015.11.003

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  18 in total

1.  Achyranthes aspera Attenuates epilepsy in experimental animals: possible involvement of GABAergic mechanism.

Authors:  Gollapalle Lakshminarayanashastry Viswanatha; Marikunte V Venkataranganna; Nunna Bheema Lingeswara Prasad; Ashok Godavarthi
Journal:  Metab Brain Dis       Date:  2017-03-06       Impact factor: 3.584

Review 2.  Vagus Nerve Stimulation for the Treatment of Epilepsy.

Authors:  Hernán F J González; Aaron Yengo-Kahn; Dario J Englot
Journal:  Neurosurg Clin N Am       Date:  2019-04       Impact factor: 2.509

3.  Multiple-Ascending Dose Study in Healthy Subjects to Assess the Pharmacokinetics, Tolerability, and CYP3A4 Interaction Potential of the T-Type Calcium Channel Blocker ACT-709478, A Potential New Antiepileptic Drug.

Authors:  Muriel Richard; Priska Kaufmann; Marion Ort; Rüdiger Kornberger; Jasper Dingemanse
Journal:  CNS Drugs       Date:  2020-03       Impact factor: 5.749

4.  EGAR, A Food Protein-Derived Tetrapeptide, Reduces Seizure Activity in Pentylenetetrazole-Induced Epilepsy Models Through α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionate Receptors.

Authors:  Song Cai; Chuwen Ling; Jun Lu; Songwei Duan; Yingzhao Wang; Huining Zhu; Ruibang Lin; Liang Chen; Xingchang Pan; Muyi Cai; Huaiyu Gu
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

5.  Temporal lobe epilepsy lateralisation and surgical outcome prediction using diffusion imaging.

Authors:  Graham W Johnson; Leon Y Cai; Saramati Narasimhan; Hernán F J González; Kristin E Wills; Victoria L Morgan; Dario J Englot
Journal:  J Neurol Neurosurg Psychiatry       Date:  2022-03-28       Impact factor: 13.654

Review 6.  Role of conventional magnetic resonance imaging in the screening of epilepsy with structural abnormalities: a pictorial essay.

Authors:  Xu Zhao; Zhiqiang Zhou; Wenzhen Zhu; Hongbing Xiang
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

7.  Effects of Low- and High-Dose Valproic Acid and Lamotrigine on the Heart in Female Rats.

Authors:  Azibe Yıldız; Nigar Vardı; Hakan Parlakpınar; Burhan Ateş; Neriman Çolakoğlu
Journal:  Cardiovasc Toxicol       Date:  2022-01-22       Impact factor: 3.231

8.  Involvement of upregulation of miR-210 in a rat epilepsy model.

Authors:  Licheng Chen; Hao Zheng; Shimeng Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-07-13       Impact factor: 2.570

Review 9.  Astroglial role in the pathophysiology of status epilepticus: an overview.

Authors:  Karina Vargas-Sánchez; Maria Mogilevskaya; John Rodríguez-Pérez; María G Rubiano; José J Javela; Rodrigo E González-Reyes
Journal:  Oncotarget       Date:  2018-06-01

10.  1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy.

Authors:  Barbara Kaproń; Robert Czarnomysy; Mariusz Wysokiński; Rudolf Andrys; Kamil Musilek; Andrea Angeli; Claudiu T Supuran; Tomasz Plech
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.